We are live on ! Find out more
MDXG icon

MiMedx Group

177 hedge funds and large institutions have $337M invested in MiMedx Group in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 57 increasing their positions, 41 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 17

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

39% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 41

31% more capital invested

Capital invested by funds: $257M → $337M (+$80M)

14% more call options, than puts

Call options by funds: $747K | Put options by funds: $658K

9% more funds holding

Funds holding: 163177 (+14)

16.1% less ownership

Funds ownership: 60.16%44.06% (-16%)

Holders
177
Holders Change
+14
Holders Change %
+8.59%
% of All Funds
2.78%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
31
Increased
57
Reduced
41
Closed
17
Calls
$747K
Puts
$658K
Net Calls
+$89K
Net Calls Change
+$48K
Name Holding Trade Value Shares
Change
Change in
Stake
DADC
51
D.A. Davidson & Co
Montana
$822K
Principal Financial Group
52
Principal Financial Group
Iowa
$813K +$460K +90,153 +274%
GC
53
Globeflex Capital
California
$788K -$17.1K -3,361 -3%
UBS Group
54
UBS Group
Switzerland
$755K +$56.5K +11,074 +11%
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$748K +$32.1K +6,294 +6%
SAM
56
Silvercrest Asset Management
New York
$735K
SO
57
STRS Ohio
Ohio
$715K -$215K -42,100 -28%
CAM
58
ClariVest Asset Management
California
$703K -$40.8K -8,000 -7%
Fidelity Investments
59
Fidelity Investments
Massachusetts
$693K +$220K +43,242 +70%
WP
60
WMS Partners
Maryland
$686K
Qube Research & Technologies (QRT)
61
Qube Research & Technologies (QRT)
United Kingdom
$676K +$178K +34,833 +52%
CIBC Private Wealth Group
62
CIBC Private Wealth Group
Georgia
$661K -$795K -155,897 -61%
Wells Fargo
63
Wells Fargo
California
$653K +$48.8K +9,574 +11%
Man Group
64
Man Group
United Kingdom
$637K +$491K +96,358 New
ECM
65
ExodusPoint Capital Management
New York
$609K +$470K +92,208 New
JP Morgan Chase
66
JP Morgan Chase
New York
$599K +$1.58K +311 +0.3%
CS
67
Credit Suisse
Switzerland
$579K +$163K +31,928 +57%
Verition Fund Management
68
Verition Fund Management
Connecticut
$563K +$373K +73,206 +610%
AA
69
ALPS Advisors
Colorado
$562K +$433K +84,971 New
TCBWMS
70
Texas Capital Bank Wealth Management Services
Texas
$529K
Citigroup
71
Citigroup
New York
$480K -$334K -65,581 -47%
Jane Street
72
Jane Street
New York
$472K +$61.5K +12,059 +20%
Legal & General Group
73
Legal & General Group
United Kingdom
$446K +$184K +36,112 +115%
Susquehanna International Group
74
Susquehanna International Group
Pennsylvania
$424K -$205K -40,122 -38%
LPL Financial
75
LPL Financial
California
$411K +$382 +75 +0.1%

MDXG Hedge Fund Activity: Q2 2023 in Review

177 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in MiMedx Group (MDXG) for Q2 2023, worth a combined $337M — up 31% from $257M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new MDXG positions and 17 closed out — a net gain of 14 holders — while 57 added to existing stakes and 41 trimmed.

The largest buyer was Millennium Management, adding an estimated $7M. The largest seller was Essex Woodlands Management, exiting entirely with an estimated $79.8M sold.

  • 177 institutional investors held MiMedx Group (MDXG) as of Q2 2023, up from 163 in Q1 2023.
  • Funds reported $337M of MiMedx Group stock for Q2 2023, up 31% quarter-over-quarter.
  • 31 funds opened new MiMedx Group positions in Q2 2023 and 17 closed out, a net change of +14 holders.
  • The largest MiMedx Group buyer in Q2 2023 was Millennium Management, an estimated $7M added.
  • The largest MiMedx Group seller in Q2 2023 was Essex Woodlands Management, an estimated $79.8M sold.

Based on aggregated 13F filings for Q2 2023.